Administrative, Education, and Analytic Support Core
行政、教育和分析支持核心
基本信息
- 批准号:10304047
- 负责人:
- 金额:$ 17.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-10 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAddressAdvisory CommitteesAgingAlcohol consumptionAlcoholic beverage heavy drinkerAlcoholsAreaBile AcidsBiological MarkersBiological Specimen BanksBiometryBloodBostonBudgetsCardiovascular DiseasesCause of DeathCessation of lifeClinical Trials Data Monitoring CommitteesCohort StudiesCollaborationsDataDiseaseEducationEnsureEventFosteringFundingFutureGoalsGrantHIVHIV InfectionsHeartInflammationInfrastructureInterventionLaboratoriesLeadLeadershipLungMentorshipMetabolic PathwayMetagenomicsMonitorNational Heart, Lung, and Blood InstituteNational Institute on Alcohol Abuse and AlcoholismPoliciesPopulationPreparationProbioticsProceduresProgram Research Project GrantsProgress ReportsProtocols documentationPublicationsRandomized Controlled TrialsResearchResearch PersonnelResourcesRisk FactorsRussiaSECTM1 geneServicesSiteSleepSpecimenTeacher Professional DevelopmentTestingTimeTrainingTraining ProgramsTranslational ResearchUgandaUnited States National Institutes of HealthUniversitiesUniversity resourcesVeteransVolatile Fatty AcidsWorkalcohol researchbiobankcardiovascular disorder riskcardiovascular risk factorcohortdata repositorydysbiosisepidemiology studyexperiencefollow-upgastrointestinalgut dysbiosisgut microbiomehigh riskimprovedinterestmeetingsmetabolomicsmicrobialmicrobiomemicrobiome researchmodifiable riskmortality riskmultidisciplinarynutritionprogram disseminationprogramsrecruitsynergismtrial designtrimethyloxamine
项目摘要
Alcohol consumption is an important modifiable cardiovascular disease (CVD) risk factor among people living
with HIV infection (PLWH). Given that alcohol use is common among PLWH, and CVD is a leading non-AIDS
disease and cause of death among PLWH, addressing alcohol consumption in this population is critically
important. The Microbiome, mETabolites, and Alcohol in HIV to reduce CVD Program Project Grant (PPG) is a
multidisciplinary group of investigators with expertise in alcohol, HIV, gut microbiome, biomarker research,
nutrition, and randomized controlled trial (RCT) design. Our overarching hypothesis for this P01 application
is that among PLWH, a probiotic can mitigate alcohol associated dysbiosis and lower levels of microbial
translocation, inflammation, and improve metabolite profiles (Project 1); and that harmful levels of these
metabolites are associated with higher risk of CVD and death events (Project 2). To test this hypothesis, this
PPG will leverage the Veterans Aging Cohort Study, the Uganda Russia Boston Alcohol Network for Alcohol
Research Collaboration on HIV/AIDS, the Integrated Metagenomic and Metabolomic Core (IMMC) at the
University of Louisville Alcohol Research Center, and the Vanderbilt SCHolars in HIV and Heart, Lung, Blood,
and Sleep ReSearch NIH K12 junior faculty training program to accomplish these objectives: (1) To determine
if a probiotic tailored for alcohol associated gut dysbiosis mitigates this dysbiosis, microbial translocation,
inflammation, harmful metabolites, CVD and mortality risk (Project 1 RCT, Lead Freiberg); (2) To assess the
association between alcohol use, CVD and death via three metabolic pathways among PLWH (Project 2
Cohort, Lead So-Armah); (3) To provide metabolomic and biomarker laboratory resources (IMMC, Lead
Barve); (4) Administrative leadership and services to support the proposed research (Admin Core, Leads
Freiberg and Barve); and (5) Encourage and develop future trainees. The Administrative (Admin) Core will be
responsible for day-to-day management and functioning of the PPG. The Admin Core goal is to ensure that
the scientific and programmatic activities of the PPG are conducted per protocol in a timely fashion, within
budget, and with the highest quality. The Admin Core has these specific aims: (1) To provide administrative
oversight of the PPG, including assembling a steering committee, program advisory committee, and data
safety monitoring board, and developing the policies and procedures necessary to successfully organize and
complete our specific aims and training initiatives; (2) To provide services to PPG investigators and trainees
(e.g., study progress reports, compliance assurance, assistance with presentations and publications), and to
promote/disseminate the PPG'S work; (3) To provide resources (e.g., data and specimens), biostatistical
support, and mentorship to new investigators ; (4) To promote synergy within and across other funded PPGs;
(5) To monitor progress and compliance of the PPG's components, implement improvement mechanisms if
necessary, and assist investigators with challenges (e.g., recruitment).
饮酒是人们生活中一个重要的可改变的心血管疾病(CVD)危险因素
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW S FREIBERG其他文献
MATTHEW S FREIBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW S FREIBERG', 18)}}的其他基金
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
HIV 中的微生物组、代谢物和酒精可减少 CVD 的随机对照试验 (META HIV CVD RCT)
- 批准号:
10685513 - 财政年份:2021
- 资助金额:
$ 17.77万 - 项目类别:
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
HIV 中的微生物组、代谢物和酒精可减少 CVD 的随机对照试验 (META HIV CVD RCT)
- 批准号:
10685704 - 财政年份:2021
- 资助金额:
$ 17.77万 - 项目类别:
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
HIV 中的微生物组、代谢物和酒精可减少 CVD 的随机对照试验 (META HIV CVD RCT)
- 批准号:
10304049 - 财政年份:2021
- 资助金额:
$ 17.77万 - 项目类别:
Administrative, Education, and Analytic Support Core
行政、教育和分析支持核心
- 批准号:
10685508 - 财政年份:2021
- 资助金额:
$ 17.77万 - 项目类别:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
范德比尔特艾滋病毒与心脏、肺、血液和睡眠研究学者(V-SCHoLARS,K12)
- 批准号:
10429901 - 财政年份:2018
- 资助金额:
$ 17.77万 - 项目类别:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
范德比尔特艾滋病毒与心脏、肺、血液和睡眠研究学者(V-SCHoLARS,K12)
- 批准号:
10202711 - 财政年份:2018
- 资助金额:
$ 17.77万 - 项目类别:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
范德比尔特艾滋病毒与心脏、肺、血液和睡眠研究学者(V-SCHoLARS,K12)
- 批准号:
9761561 - 财政年份:2018
- 资助金额:
$ 17.77万 - 项目类别:
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk
英石。
- 批准号:
9349871 - 财政年份:2017
- 资助金额:
$ 17.77万 - 项目类别:
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk
英石。
- 批准号:
9770731 - 财政年份:2017
- 资助金额:
$ 17.77万 - 项目类别:
Immune function and the risk of cvd among HIV infected and uninfected veterans
HIV感染者和未感染者的免疫功能和CVD风险
- 批准号:
9268918 - 财政年份:2014
- 资助金额:
$ 17.77万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 17.77万 - 项目类别:
Research Grant














{{item.name}}会员




